OVARIAN CANCER and US: stress

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label stress. Show all posts
Showing posts with label stress. Show all posts

Monday, April 09, 2012

abstract: Psychiatric morbidity in gynecological outpatients



Psychiatric morbidity in gynecological outpatients - Judd - 2012 - Journal of Obstetrics and Gynaecology Research

Abstract

Aim:  To assess the prevalence of depression and anxiety in women presenting with gynecological symptoms, to determine how many women with these disorders were receiving treatment for them, and to investigate risk factors for these disorders.
Method:  Two hundred and sixty-four women seeking medical care from gynecology clinics at a specialist women's hospital completed a self-report questionnaire asking about sociodemographics, physical and mental health, personality (neuroticism) and psychosocial stressors.
Results:  A total of 91 women met the diagnostic criteria for one or more Patient Health Questionnaire (PHQ) diagnosis. Forty-six (17.4%) met criteria for major depressive disorder (MDD), 15 (5.7%) for panic disorder (PD) and 73 (27.7%) for generalized anxiety disorder (GAD). Thirty-nine (42.9%) of the 91 women met criteria for two or more disorders. An additional 23 (8.7%) met DSM-IV-TR criteria for minor (sub-threshold) depression. Fifty percent with MDD, 4% with minor depression, 53% with PD and 22% with GAD reported they were receiving treatment. Psychosocial stressors and the neuroticism score were risk factors for both anxiety and depression.
Conclusions:  Anxiety and depression are common amongst women attending a gynecology clinic. Clinicians should be alert to the possibility of these disorders and make specific enquiries about their emotional wellbeing.

Friday, April 06, 2012

Witnessing, Experiencing Traumatic Events May Worsen Heart Disease - MedicineNet



Witnessing, Experiencing Traumatic Events May Worsen Heart Disease - MedicineNet

WEDNESDAY, April 4 (HealthDay News) -- Large amounts of lifetime exposure to traumatic stress -- even when it doesn't result in post-traumatic stress disorder -- boosts inflammation levels in heart disease patients, a new study suggests.......

Tuesday, April 03, 2012

news: Increased risk of cardiovascular disease for relatives of cancer patients



Increased risk of cardiovascular disease for relatives of cancer patients

 03 April 2012 Lund University
 
A current study shows that the risk for coronary heart disease and stroke increases by almost thirty per cent in a person whose partner has cancer. The cause is probably the negative stress to which the cancer patient’s relative is exposed......

Tuesday, March 27, 2012

research news: When we test, do we stress?



Blogger's Note:  interesting article, reminds me of the 'white coat' factor

"On the basis of these results, the CSHS team questioned over 150 older people, asking them to describe the situations they find stressful when they have to go to various medical environments. On March 29, during the scientific day “When we test, do we stress?” ( http://bit.ly/H9UdLn ), the CSHS researchers will reveal the results of this survey on stress induced in older people by medical settings and the testing environments......

When we test, do we stress?

Tuesday, March 13, 2012

abstract: Oncologist Burnout: Causes, Consequences, and Responses



Oncologist Burnout: Causes, Consequences, and Responses

 Abstract
"Although the practice of oncology can be extremely rewarding, it is also one of the most demanding and stressful areas of medicine. Oncologists are faced with life and death decisions on a daily basis, administer incredibly toxic therapies with narrow therapeutic windows, must keep up with the rapid pace of scientific and treatment advances, and continually walk a fine line between providing palliation and administering treatments that lead to excess toxicity. Personal distress precipitated by such work-related stress may manifest in a variety of ways including depression, anxiety, fatigue, and low mental quality of life. Burnout also seems to be one of the most common manifestations of distress among physicians, with studies suggesting a prevalence of 35% among medical oncologists, 38% among radiation oncologists, and 28% to 36% among surgical oncologists. Substantial evidence suggests that burnout can impact quality of care in a variety of ways and has potentially profound personal implications for physicians including suicidal ideation. In this review, we examine the causes, consequences, and personal ramifications of oncologist burnout and explore the steps oncologists can take to promote personal well-being and professional satisfaction."

Sunday, March 06, 2011

Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients - Full Text View - ClinicalTrials.gov



Note Exclusion criteria
Exclusion Criteria:    a. Patients who receive neoadjuvant chemotherapy for their ovarian, primary peritoneal, or fallopian tube cancer are excluded....

Purpose
This research is looking at the effect of biobehavioral factors such as stress and whether these factors alter how the body responds to chemotherapy, one of the purposes of this study is to determine if the addition of a beta-blocker such as Propranolol (Inderal) is tolerable when given with chemotherapy in the treatment of newly diagnosed ovarian, fallopian tube, or primary peritoneal cancer. An additional purpose of the study is to understand if behavioral factors such as depression and anxiety can alter different blood markers that affect tumor vascularity. The Investigator wishes to determine whether the use of beta-blocker drugs such as Inderal, might alter these behavioral factors by drawing blood prior to and after the administration of Inderal as well as giving behavioral questionaires at different time points. Beta-blockers are commonly used for the treatment of hypertension, protection of the heart after a heart attack, and irregularities in heartbeats. Altering these factors might boost the immune system and affect other areas of cancer biology, thereby allowing the chemotherapy to be more effective. The significance of this research is that it may help improve our treatments of this disease in the future.